SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-368383
Filing Date
2015-11-05
Accepted
2015-11-05 16:34:44
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d31962d10q.htm 10-Q 622274
2 EX-31.1 d31962dex311.htm EX-31.1 6048
3 EX-32.1 d31962dex321.htm EX-32.1 3298
  Complete submission text file 0001193125-15-368383.txt   3523786

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT alxa-20150930.xml EX-101.INS 557880
5 XBRL TAXONOMY EXTENSION SCHEMA alxa-20150930.xsd EX-101.SCH 43036
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20150930_cal.xml EX-101.CAL 56187
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20150930_def.xml EX-101.DEF 139495
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20150930_lab.xml EX-101.LAB 359457
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20150930_pre.xml EX-101.PRE 252368
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 151201218
SIC: 2834 Pharmaceutical Preparations